Clinical Trial: ALTARGO(Retapamulin) PMS(Post-marketing Surveillance)

Study Status: Completed
Recruit Status: Completed
Study Type: Observational




Official Title: An Open Label, Multi-centre, Non-interventional Post-marketing Surveillance (PMS) to Monitor the Safety and Efficacy of ALTARGO(Retapamulin) Administered in Korean Patients According to the Prescribin

Brief Summary: This is an open label, multi-centre, non-interventional post-marketing surveillance.